, Best Practices
, Health Behavior
, Health Policy
, Health Promotion
, Infectious Disease
, Primary Care
, Risk Management
, STDs (Sexually Transmitted Infections)
, Viral Infections
Release Date: February 10, 2017
Expiration Date: February 28, 2018 (subject to change)
- CE for this activity will not be available after this date.
Reference Number: 16112433
A post impact survey invitation will be sent to all learners who complete this activity (see below). Participation is completely optional.
Computer Requirements: The activity can be viewed in any browser, but the preferred browser for this Adobe PDF publication is Firefox
Despite guidelines from the Centers for Disease Control and Prevention and the United States Preventive Services Task Force that advocate for universal opt-out HIV testing of adolescents and adults, recent evidence suggests that these recommendations are not routinely followed in clinical practice. Indeed, an estimated 13% of the 1.2 million individuals living with HIV in the United States are undiagnosed and, therefore, unable to receive the care and education they need to reduce the risk of transmission and HIV-related morbidity and mortality. In addition, 34% of patients with HIV are not engaged in HIV medical care following diagnosis. Screening for HIV and linking newly diagnosed individuals into HIV medical care are relevant challenges for primary care providers, who face increasing demands due to a growing patient population and shortage of HIV specialists.
This activity is intended for primary care clinicians, including physicians, nurse practitioners, physician assistants, and nurses.
- Describe the rationale for universal HIV testing of adolescents and adults
- Apply universal HIV testing recommendations in practice
- Identify common barriers to linking patients with newly diagnosed HIV to medical care
Lisa Fitzpatrick, MD, MPH
Jason E. Farley, PhD, MPH, ANP-BC, FAAN, AACRN
Jeffrey Kwong, DNP, MPH, ANP-BC, FAANP
This activity was planned in accordance with AANP Accreditation Standards and Policies in collaboration with Med-IQ. It is supported by an educational grant from Gilead Sciences, Inc.
- Lisa Fitzpatrick, MD, MPH, has indicated no real or apparent conflicts.
- Jason E. Farley, PhD, MPH, ANP-BC, FAAN, AACRN: Consulting fees/advisory boards: Gilead Sciences, Inc.
- Jeffrey Kwong, DNP, MPH, ANP-BC, FAANP Consulting fees/advisory boards: Gilead Sciences, Inc.
- The writers, peer reviewers, and activity planners have no financial relationships to disclose.
This educational activity may contain opinions of the speakers from their personal experience. The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
To complete the CE/CME for this activity, review all the content, successfully complete the online post-test and submit the online program evaluation.
- Nurse Practitioners: This activity is approved for 1.0 contact hour of continuing education by the American Association of Nurse Practitioners. Activity ID 16112433. This activity was planned in accordance with AANP CE Standards and Policies
- Physicians: Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Med-IQ designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Nurses: Med-IQ is accredited by the California Board of Registered Nursing to provide continuing education to nurses. Provider approved by the California Board of Registered Nursing, provider number CEP 14745, for 1.0 contact hour.
- Others: Physician assistants and other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.
Post Impact Survey
Between 30 to 90 days after this activity is completed, AANP will send out an invitation to participate in a Post Impact Outcomes Survey (PI Survey) . Participation in the survey is optional and does not affect the credit earned. The PI surveys help measure the overall impact of the education content, see how the material impacts practice behaviors and what changes are being made. This anonymous information is crucial in helping the Education department improve current activities as well as guiding AANP in planning future CE activities.
For questions about this online CE/CME activity, or more information concerning the AANP CE Center, contact the AANP CE Center Manager at CECenter@aanp.org.
© 2017 Med-IQ and the American Association of Nurse Practitioners. All rights reserved.